Belay Diagnostics Wins Palantir Buildcamp Competition for Second Consecutive Year
Belay Diagnostics has secured first place in Palantir's Foundry for Builders Buildcamp for the second year running. During the competition, the company developed a molecular case review prototype that integrates patient medical histories with cerebrospinal fluid (CSF) liquid biopsy results into a single interactive timeline to assist neuro-oncologists. The company utilizes Palantir Foundry to power its proprietary technology platform, which streamlines clinical, laboratory, and business operations. This infrastructure supports Belay's specialized testing for central nervous system (CNS) cancers, including their Summit™ 2.0, Ascent™, and Vantage™ products. In addition to this technological milestone, Belay recently achieved SOC 2 attestation, signaling enhanced data security protocols as the company scales its diagnostic services and revenue cycle management tools.
Tickers: $PLTR
Topics: Healthcare Technology Molecular Diagnostics Palantir Foundry Software Development